Nicolai Nymann Smed ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.0% 4.4% 4.0% 4.6% 4.3%  
Credit score (0-100)  45 47 48 45 47  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  469 499 489 384 511  
EBITDA  132 178 159 36.5 160  
EBIT  94.9 122 95.8 -12.9 124  
Pre-tax profit (PTP)  93.9 120.9 92.6 -15.3 122.9  
Net earnings  72.4 94.2 72.1 -12.0 95.5  
Pre-tax profit without non-rec. items  93.9 121 92.6 -15.3 123  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  106 122 97.5 75.6 108  
Shareholders equity total  220 314 386 374 470  
Interest-bearing liabilities  3.0 0.6 4.4 8.2 2.9  
Balance sheet total (assets)  422 580 534 494 606  

Net Debt  -230 -312 -379 -223 -360  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  469 499 489 384 511  
Gross profit growth  3.7% 6.4% -2.1% -21.5% 33.0%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  422 580 534 494 606  
Balance sheet change%  51.6% 37.5% -7.9% -7.5% 22.6%  
Added value  132.4 177.8 159.1 50.3 160.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  20 -40 -88 -71 -4  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  20.2% 24.3% 19.6% -3.4% 24.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  27.1% 24.3% 17.2% -2.5% 22.6%  
ROI %  50.7% 45.1% 27.2% -3.3% 29.1%  
ROE %  39.4% 35.3% 20.6% -3.1% 22.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  52.2% 54.2% 72.4% 75.8% 77.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -173.4% -175.3% -238.0% -609.6% -224.5%  
Gearing %  1.3% 0.2% 1.1% 2.2% 0.6%  
Net interest  0 0 0 0 0  
Financing costs %  47.1% 37.5% 127.5% 37.6% 26.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.6 1.7 3.0 3.5 3.7  
Current Ratio  1.6 1.7 3.0 3.5 3.7  
Cash and cash equivalent  232.6 312.3 383.1 230.7 363.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  115.3 192.3 288.9 298.9 362.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  132 178 159 50 160  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  132 178 159 37 160  
EBIT / employee  95 122 96 -13 124  
Net earnings / employee  72 94 72 -12 96